STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer von Wang, Qiwei, Bergholz, Johann S., Ding, Liya, Lin, Ziying, Kabraji, Sheheryar K., Hughes, Melissa E., He, Xiadi, Xie, Shaozhen, Jiang, Tao, Wang, Weihua, Zoeller, Jason J., Kim, Hye-Jung, Roberts, Thomas M., Konstantinopoulos, Panagiotis A., Matulonis, Ursula A., Dillon, Deborah A., Winer, Eric P., Lin, Nancy U., Zhao, Jean J.

Volltext

ICAM-1 as a molecular target for triple negative breast cancer von Guo, Peng, Huang, Jing, Wang, Liya, Di Jia, Yang, Jiang, Dillon, Deborah A., Zurakowski, David, Mao, Hui, Moses, Marsha A., Auguste, Debra T.

Volltext

A human breast atlas integrating single-cell proteomics and transcriptomics von Gray, G. Kenneth, Li, Carman Man-Chung, Rosenbluth, Jennifer M., Selfors, Laura M., Girnius, Nomeda, Lin, Jia-Ren, Schackmann, Ron C.J., Goh, Walter L., Moore, Kaitlin, Shapiro, Hana K., Mei, Shaolin, D’Andrea, Kurt, Nathanson, Katherine L., Sorger, Peter K., Santagata, Sandro, Regev, Aviv, Garber, Judy E., Dillon, Deborah A., Brugge, Joan S.

Volltext

Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis von Calligaris, David, Caragacianu, Diana, Liu, Xiaohui, Norton, Isaiah, Thompson, Christopher J., Richardson, Andrea L., Golshan, Mehra, Easterling, Michael L., Santagata, Sandro, Dillon, Deborah A., Jolesz, Ferenc A., Agar, Nathalie Y. R.

Volltext

Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy von Church, Alanna J, Calicchio, Monica L, Nardi, Valentina, Skalova, Alena, Pinto, Andre, Dillon, Deborah A, Gomez-Fernandez, Carmen R, Manoj, Namitha, Haimes, Josh D, Stahl, Joshua A, Dela Cruz, Filemon S, Tannenbaum-Dvir, Sarah, Glade-Bender, Julia L, Kung, Andrew L, DuBois, Steven G, Kozakewich, Harry P, Janeway, Katherine A, Perez-Atayde, Antonio R, Harris, Marian H

Volltext

p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases von Ni, Jing, Kabraji, Sheheryar, Xie, Shaozhen, Wang, Yanzhi, Pan, Peichen, He, Xiaofang, Liu, Zongming, Leone, Jose Palbo, Long, Henry W., Brown, Myles A., Winer, Eric P., Dillon, Deborah A. R., Lin, Nancy U., Zhao, Jean J.

Volltext

Metabolic abnormalities and survival among patients with non-metastatic breast cancer von Zimbalist, Alexa S, Caan, Bette J, Chen, Wendy Y, Mittendorf, Elizabeth A, Dillon, Deborah A R, Quesenberry, Charles, Cespedes Feliciano, Elizabeth M

Volltext

Trastuzumab for the Treatment of Salivary Duct Carcinoma von Limaye, Sewanti A., Posner, Marshall R., Krane, Jeffrey F., Fonfria, Maria, Lorch, Jochen H., Dillon, Deborah A., Shreenivas, Aditya V., Tishler, Roy B., Haddad, Robert I.

Volltext

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor von Lu, Gang, Zhang, Qing, Huang, Ying, Song, Jiaxi, Tomaino, Ross, Ehrenberger, Tobias, Lim, Elgene, Liu, Wenbin, Bronson, Roderick T., Bowden, Michaela, Brock, Jane, Krop, Ian E., Dillon, Deborah A., Gygi, Steven P., Mills, Gordon B., Richardson, Andrea L., Signoretti, Sabina, Yaffe, Michael B., Kaelin, William G.

Volltext

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer von Zoeller, Jason J, Vagodny, Aleksandr, Daniels, Veerle W, Taneja, Krishan, Tan, Benjamin Y, DeRose, Yoko S, Fujita, Maihi, Welm, Alana L, Letai, Anthony, Leverson, Joel D, Blot, Vincent, Bronson, Roderick T, Dillon, Deborah A, Brugge, Joan S

Volltext

Loss of SMAD4 protein expression in gastrointestinal and extra‐gastrointestinal carcinomas von Ritterhouse, Lauren L, Wu, Elizabeth Yiru, Kim, Woo Gyeong, Dillon, Deborah A, Hirsch, Michelle S, Sholl, Lynette M, Agoston, Agoston T, Setia, Namrata, Lauwers, Gregory Y, Park, Do Youn, Srivastava, Amitabh, Doyle, Leona A

Volltext

In Vitro Liquid Extraction Surface Analysis Mass Spectrometry (ivLESA-MS) for Direct Metabolic Analysis of Adherent Cells in Culture von Basu, Sankha S, Randall, Elizabeth C, Regan, Michael S, Lopez, Begoña G.C, Clark, Amanda R, Schmitt, Nicholas D, Agar, Jeffrey N, Dillon, Deborah A, Agar, Nathalie Y. R

Volltext

Integrative multiomics-histopathology analysis for breast cancer classification von Ektefaie, Yasha, Yuan, William, Dillon, Deborah A., Lin, Nancy U., Golden, Jeffrey A., Kohane, Isaac S., Yu, Kun-Hsing

Volltext

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors von Goel, Shom, Wang, Qi, Watt, April C., Tolaney, Sara M., Dillon, Deborah A., Li, Wei, Ramm, Susanne, Palmer, Adam C., Yuzugullu, Haluk, Varadan, Vinay, Tuck, David, Harris, Lyndsay N., Wong, Kwok-Kin, Liu, X. Shirley, Sicinski, Piotr, Winer, Eric P., Krop, Ian E., Zhao, Jean J.

Volltext

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer von Tolaney, Sara M, Guo, Hao, Pernas, Sonia, Barry, William T, Dillon, Deborah A, Ritterhouse, Lauren, Schneider, Bryan P, Shen, Fei, Fuhrman, Kit, Baltay, Michele, Dang, Chau T, Yardley, Denise A, Moy, Beverly, Marcom, P Kelly, Albain, Kathy S, Rugo, Hope S, Ellis, Mathew J, Shapira, Iuliana, Wolff, Antonio C, Carey, Lisa A, Overmoyer, Beth, Partridge, Ann H, Hudis, Clifford A, Krop, Ian E, Burstein, Harold J, Winer, Eric P

Volltext

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer von Stover, Daniel G, Parsons, Heather A, Ha, Gavin, Freeman, Samuel S, Barry, William T, Guo, Hao, Choudhury, Atish D, Gydush, Gregory, Reed, Sarah C, Rhoades, Justin, Rotem, Denisse, Hughes, Melissa E, Dillon, Deborah A, Partridge, Ann H, Wagle, Nikhil, Krop, Ian E, Getz, Gad, Golub, Todd R, Love, J Christopher, Winer, Eric P, Tolaney, Sara M, Lin, Nancy U, Adalsteinsson, Viktor A

Volltext

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer von Guerriero, Jennifer L., Lin, Jia-Ren, Pastorello, Ricardo G., Du, Ziming, Chen, Yu-An, Townsend, Madeline G., Shimada, Kenichi, Hughes, Melissa E., Ren, Siyang, Tayob, Nabihah, Zheng, Kelly, Mei, Shaolin, Patterson, Alyssa, Taneja, Krishan L., Metzger, Otto, Tolaney, Sara M., Lin, Nancy U., Dillon, Deborah A., Schnitt, Stuart J., Sorger, Peter K., Mittendorf, Elizabeth A., Santagata, Sandro

Volltext

Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery von Basu, Sankha S., Stopka, Sylwia A., Abdelmoula, Walid M., Randall, Elizabeth C., Gimenez-Cassina Lopez, Begoña, Regan, Michael S., Calligaris, David, Lu, Fake F., Norton, Isaiah, Mallory, Melissa A., Santagata, Sandro, Dillon, Deborah A., Golshan, Mehra, Agar, Nathalie Y. R.

Volltext

Histopathologic features of breast cancer in Li–Fraumeni syndrome von Kuba, M. Gabriela, Lester, Susan C., Bowman, Teresa, Stokes, Samantha M., Taneja, Krishan L., Garber, Judy E., Dillon, Deborah A.

Volltext

HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer von Xia, Daniel, Kuo, Frank, Hughes, Melissa, Lindeman, Neal, Manning, Danielle, Files, Janet, Strauss, Sarah, Kirkner, Greg, Mohammed-Abreu, Ayesha, Winer, Eric, Tolaney, Sara M, Lin, Nancy U, Dillon, Deborah A

Volltext